secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001104659-24-081888
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics CSO Jack Syage resigns; salary cut to $66,560 as cost reduction
--------------------------------------------------------------------------------

- Dr. Jack Syage resigned as Chief Scientific Officer effective July 17, 2024, will remain President and Board member.
- Resignation is part of cost reduction measures, not due to any disagreement with company policies.
- Annual base salary reduced to $66,560, effective July 1, 2024; other compensation terms unchanged.
- CEO James Sapirstein signed the filing on July 23, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924081888/0001104659-24-081888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924081888/tm2419937d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-081888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer